S100A8 and myeloproliferative neoplasm: With all driver mutations (including both type 1 and type 2 CALR mutations) of MPN led to constitutive activation of JAK/STAT signaling, our results demonstrating that STAT3 preferentially regulated the transcription of S100a8 in CALRDEL cells but not in CALRINS cells were rather interesting.